-
Loading metrics
Open Access
Peer-reviewed
Research Article
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
-
Toshihiro Yoneyama,
Affiliation Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
⨯ -
Sumio Ohtsuki ,
* E-mail: sohtsuki@kumamoto-u.ac.jp
Affiliations Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, Japan Agency for Medical Research and Development (AMED) CREST, Tokyo, Japan
⨯ -
Kazufumi Honda,
Affiliations Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, Japan, Japan Agency for Medical Research and Development (AMED) CREST, Tokyo, Japan
⨯ -
Makoto Kobayashi,
Affiliation Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, Japan
⨯ -
Motoki Iwasaki,
Affiliation Division of Epidemiology, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
⨯ -
Yasuo Uchida,
Affiliation Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
⨯ -
Takuji Okusaka,
Affiliation Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
⨯ -
Shoji Nakamori,
Affiliation Departments of Hepato-Biliary-Pancreatic Surgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan
⨯ -
Masashi Shimahara,
Affiliation Department of Oral Surgery, Osaka Medical College, Osaka, Japan
⨯ -
Takaaki Ueno,
Affiliation Department of Oral Surgery, Osaka Medical College, Osaka, Japan
⨯ -
Akihiko Tsuchida,
Affiliation Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
⨯ -
Naohiro Sata,
Affiliation Department of Surgery, Jichi Medical University, Tochigi, Japan
⨯ -
Tatsuya Ioka,
Affiliation Department of Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
⨯ -
Yohichi Yasunami,
Affiliation Islet Institute, Fukuoka University, Fukuoka, Japan
⨯ -
Tomoo Kosuge,
Affiliation Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
⨯ -
Takashi Kaneda,
Affiliation Department of Radiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan
⨯ -
Takao Kato,
Affiliation Department of Oral Implant, Nihon University School of Dentistry at Matsudo, Chiba, Japan
⨯ -
Kazuhiro Yagihara,
Affiliation Department of Oral Surgery, Saitama Cancer Center, Saitama, Japan
⨯ -
Shigeyuki Fujita,
Affiliation Department of Oral and Maxillofacial Surgery, Wakayama Medical University, Wakayama, Japan
⨯ -
Wilber Huang,
Affiliation Abnova, Taipei City, Taiwan
⨯ -
Tesshi Yamada,
Affiliation Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, Tokyo, Japan
⨯ -
Masanori Tachikawa,
Affiliation Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
⨯ - [ ... ],
-
Tetsuya Terasaki
Affiliation Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
⨯ - [ view all ]
- [ view less ]
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
- Toshihiro Yoneyama,
- Sumio Ohtsuki,
- Kazufumi Honda,
- Makoto Kobayashi,
- Motoki Iwasaki,
- Yasuo Uchida,
- Takuji Okusaka,
- Shoji Nakamori,
- Masashi Shimahara,
- Takaaki Ueno
- Published: August 31, 2016
- https://doi.org/10.1371/journal.pone.0161009